Masaru Matsuda, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 3,314 shares at $30.23 ($100K) on 2025-12-01, disclosed to the SEC on 2025-12-03.
Scheduled sale ($100k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.23 | 1,657 | $50K | 50.0% |
| 2 | $30.23 | 1,657 | $50K | 50.0% |
| Total | $30.23 avg | 3,314 | $100K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $32K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $192K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $314K | — | Filing → |